← Leaderboards
Andrew Liss
Massachusetts General Hospital
$1,611,089
Attributed
$1,938,187
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,938,187 · 3
By mechanism
R01$1,772,091 · 2
R03$166,096 · 1
Top collaborators
- Ralph Weissleder1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Frederick M Ausubel$22,351,893
- Leif W Ellisen$14,503,955
- Roby Paul Bhattacharyya$4,624,355
- J. Keith Joung$24,183,955
- Maha Farhat$7,486,819
Others in their field
Other Emerging Leaders on “Cessation Of Life”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Abraham Aizer Brody · New York University School Of Medicine$21,799,826
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
- Jeffrey Reich · Sparian Biosciences, Inc.$20,633,040
- Beth Baseler · Leidos Biomedical Research, Inc.$18,109,529
Research focus
Cessation Of LifePublishingTumorExperimental StudyMalignant NeoplasmsTumor XenograftPancreatic Ductal AdenocarcinomaResponseUnited StatesCell LineGenetic TranscriptionGenesMalignant Neoplasm Of PancreasInsightCancer EtiologyMediatingCellsInnovationCollectionChromatinChemotherapyBiologyChemoresistanceExpression Profiling
Grant awards (5)
Pancreatic cancer patient-derived xenograft tumors for translational studies in precision cancer medicine$654,197
R01 · FY2025 · CA · contact PI
Epigenetic regulation of pancreatic cancer subtype identity and tumorigenesis by PHF2$378,947
R01 · FY2025 · CA · contact PI
Epigenetic regulation of pancreatic cancer subtype identity and tumorigenesis by PHF2$360,000
R01 · FY2024 · CA · contact PI
Epigenetic regulation of pancreatic cancer subtype identity and tumorigenesis by PHF2$378,947
R01 · FY2023 · CA · contact PI
Epigenetic Regulation of Hemidesmosome Signaling in Pancreatic Cancer$166,096
R03 · FY2020 · CA · contact PI